Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Tal Zvi Zaks. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Tal Zvi Zaks har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) | Director | 58 772 |
US:MRNA / Moderna, Inc. | Chief Medical Officer | 121 120 |
US:ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) | Director | 379 788 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Tal Zvi Zaks. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Tal Zvi Zaks som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-09 |
|
4 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares |
M - Exercise | 9 632 | 58 772 | 19,60 | ||||
2024-06-17 |
|
4 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares |
M - Exercise | 21 108 | 49 140 | 75,30 | ||||
2023-08-07 |
|
4 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares |
M - Exercise | 15 810 | 28 032 | 129,36 | ||||
2022-11-07 |
|
4 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares |
M - Exercise | 12 205 | 12 222 | 71 794,12 | ||||
2022-02-10 |
|
5 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares |
L - Other | 17 | 17 | 8,88 | 151 | 151 | ||
2021-11-08 |
|
4 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units |
A - Award | 12 205 | 12 205 | |||||
2021-07-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 121 120 | −3,96 | |||
2021-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 237,00 | −1 185 000 | |
2021-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-07-02 |
|
4 | ADAP |
Adaptimmune Therapeutics PLC
Option to purchase Ordinary Shares |
A - Award | 379 788 | 379 788 | |||||
2021-06-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 126 120 | −3,81 | |||
2021-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 219,65 | −1 098 250 | |
2021-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-06-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 131 120 | −3,67 | |||
2021-06-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 200,00 | −1 000 000 | |
2021-06-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-06-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 136 120 | −3,54 | |||
2021-06-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 212,30 | −1 061 500 | |
2021-06-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 141 120 | −3,42 | |||
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 183,90 | −919 500 | |
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-05-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 146 120 | −3,31 | |||
2021-05-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 168,70 | −843 500 | |
2021-05-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-05-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 151 120 | −3,20 | |||
2021-05-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 155,74 | −778 700 | |
2021-05-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-05-13 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 156 120 | −3,10 | |||
2021-05-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 154,11 | −770 550 | |
2021-05-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 25,93 | 129 650 | 129 650 | |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −3 670 | 137 612 | −2,60 | |||
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 163,12 | −32 624 | |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 200 | −33,33 | 161,64 | −16 164 | 32 328 |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 300 | −40,00 | 159,63 | −31 926 | 47 889 |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 585 | 500 | −76,02 | 158,88 | −251 825 | 79 440 |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −985 | 2 085 | −32,08 | 157,48 | −155 118 | 328 346 |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −600 | 3 070 | −16,35 | 156,60 | −93 960 | 480 762 |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 3 670 | 3 670 | 12,21 | 44 811 | 44 811 | |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 141 282 | −3,42 | |||
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −916 | 0 | −100,00 | 188,00 | −172 208 | |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 924 | 916 | −67,75 | 187,10 | −359 980 | 171 384 |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 089 | 2 840 | −27,72 | 186,04 | −202 598 | 528 354 |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 3 929 | −16,92 | 184,77 | −147 816 | 725 961 |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −271 | 4 729 | −5,42 | 183,42 | −49 707 | 867 393 |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 146 282 | −3,31 | |||
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 179,37 | −17 937 | |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 829 | 100 | −94,82 | 178,51 | −326 495 | 17 851 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −900 | 1 929 | −31,81 | 177,41 | −159 669 | 342 224 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −551 | 2 829 | −16,30 | 175,97 | −96 959 | 497 819 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 3 380 | −10,58 | 175,03 | −70 012 | 591 601 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 3 780 | −5,03 | 173,03 | −34 606 | 654 053 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 | 3 980 | −0,03 | 171,65 | −172 | 683 167 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −439 | 3 981 | −9,93 | 171,05 | −75 091 | 680 950 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −580 | 4 420 | −11,60 | 169,87 | −98 525 | 750 825 |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 151 282 | −3,20 | |||
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 167,56 | −16 756 | |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 100 | −87,50 | 166,31 | −116 417 | 16 631 |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −462 | 800 | −36,61 | 165,04 | −76 248 | 132 032 |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −500 | 1 262 | −28,38 | 163,89 | −81 945 | 206 829 |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 250 | 1 762 | −41,50 | 162,65 | −203 312 | 286 589 |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 332 | 3 012 | −30,66 | 161,62 | −215 278 | 486 799 |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −656 | 4 344 | −13,12 | 160,48 | −105 275 | 697 125 |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 156 282 | −3,10 | |||
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 143,09 | −14 309 | |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 100 | −80,00 | 141,79 | −56 716 | 14 179 |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −413 | 500 | −45,24 | 140,22 | −57 911 | 70 110 |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 824 | 913 | −66,64 | 139,38 | −254 229 | 127 254 |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 400 | 2 737 | −33,84 | 138,06 | −193 284 | 377 870 |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −863 | 4 137 | −17,26 | 137,16 | −118 369 | 567 431 |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 161 282 | −3,01 | |||
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 150 | 0 | −100,00 | 130,95 | −150 592 | |
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 426 | 2 574 | −48,52 | 129,96 | −315 283 | 334 517 |
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −814 | 1 150 | −41,45 | 128,65 | −104 721 | 147 948 |
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −610 | 1 964 | −23,70 | 127,76 | −77 934 | 250 921 |
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 199 | 169 599 | −0,70 | |||
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −61 | 0 | −100,00 | 147,50 | −8 998 | |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −290 | 61 | −82,62 | 146,46 | −42 473 | 8 934 |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −227 | 351 | −39,27 | 145,47 | −33 022 | 51 060 |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −366 | 578 | −38,77 | 144,06 | −52 726 | 83 267 |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −255 | 944 | −21,27 | 142,83 | −36 422 | 134 832 |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 1 199 | 1 199 | 20,93 | 25 095 | 25 095 | |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −34 | 40 141 | −0,08 | |||
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 170 798 | −5,53 | |||
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −957 | 0 | −100,00 | 143,09 | −136 937 | |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 101 | 957 | −68,71 | 142,17 | −298 699 | 136 057 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 988 | 3 058 | −49,42 | 141,31 | −422 234 | 432 126 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 874 | 6 046 | −23,66 | 140,38 | −263 072 | 848 737 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 7 920 | −3,65 | 139,09 | −41 727 | 1 101 593 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −602 | 8 220 | −6,82 | 138,26 | −83 233 | 1 136 497 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −801 | 8 822 | −8,32 | 137,00 | −109 737 | 1 208 614 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −411 | 9 623 | −4,10 | 136,00 | −55 896 | 1 308 728 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 34 | 10 034 | 0,34 | 14,22 | 483 | 142 683 |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 40 175 | −11,07 | |||
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 478 | 0 | −100,00 | |||
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 180 798 | −5,24 | |||
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −471 | 0 | −100,00 | 132,91 | −62 601 | |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 471 | −80,94 | 131,83 | −263 660 | 62 092 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 611 | 2 471 | −51,38 | 130,76 | −341 414 | 323 108 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 312 | 5 082 | −31,27 | 129,80 | −300 098 | 659 644 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 698 | 7 394 | −26,73 | 128,62 | −347 017 | 951 016 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 855 | 10 092 | −15,53 | 127,73 | −236 939 | 1 289 051 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 350 | 11 947 | −10,15 | 126,75 | −171 112 | 1 514 282 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 361 | 13 297 | −9,29 | 125,68 | −171 050 | 1 671 167 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −273 | 14 658 | −1,83 | 124,35 | −33 948 | 1 822 722 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 547 | 14 931 | −9,39 | 123,48 | −191 024 | 1 843 680 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 16 478 | 43,56 | 14,22 | 71 100 | 234 317 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 1 478 | 11 478 | 14,78 | 12,21 | 18 046 | 140 146 |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 45 175 | −9,97 | |||
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 45 175 | −9,97 | |||
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −450 | 0 | −100,00 | 157,29 | −70 780 | |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −771 | 450 | −63,14 | 156,49 | −120 654 | 70 420 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −600 | 1 221 | −32,95 | 155,69 | −93 414 | 190 097 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −753 | 1 821 | −29,25 | 154,34 | −116 218 | 281 053 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −900 | 2 574 | −25,91 | 152,01 | −136 809 | 391 274 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −600 | 3 474 | −14,73 | 150,86 | −90 516 | 524 088 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 039 | 4 074 | −20,32 | 149,79 | −155 632 | 610 244 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 5 113 | −12,04 | 149,00 | −104 300 | 761 837 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 986 | 5 813 | −25,46 | 147,71 | −293 352 | 858 638 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 201 | 7 799 | −22,01 | 146,68 | −322 843 | 1 143 957 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 10 000 | 100,00 | 14,22 | 71 100 | 142 200 |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 6 478 | −43,56 | |||
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 169,81 | −16 981 | |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −281 | 100 | −73,75 | 168,90 | −47 461 | 16 890 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −356 | 381 | −48,30 | 168,00 | −59 808 | 64 008 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 737 | −48,71 | 166,82 | −116 774 | 122 946 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 000 | 1 437 | −41,03 | 165,95 | −165 950 | 238 470 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 2 437 | −10,96 | 164,60 | −49 380 | 401 130 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 100 | 2 737 | −28,67 | 163,57 | −179 927 | 447 691 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 3 837 | −17,25 | 162,47 | −129 976 | 623 397 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 4 637 | −2,11 | 160,38 | −16 038 | 743 682 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −263 | 4 737 | −5,26 | 159,32 | −41 901 | 754 699 |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −3 670 | 166 282 | −2,16 | |||
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 0 | −100,00 | 186,84 | −149 472 | |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −566 | 800 | −41,43 | 185,82 | −105 174 | 148 656 |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 404 | 1 366 | −50,69 | 185,03 | −259 782 | 252 751 |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 2 770 | −12,62 | 182,92 | −73 168 | 506 688 |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 3 170 | −3,06 | 180,74 | −18 074 | 572 946 |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 3 270 | −8,40 | 179,43 | −53 829 | 586 736 |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 3 570 | −2,72 | 178,20 | −17 820 | 636 174 |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 3 670 | 3 670 | 12,21 | 44 811 | 44 811 | |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 169 952 | −2,86 | |||
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 174,00 | −17 400 | |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 100 | −87,50 | 172,86 | −121 002 | 17 286 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 800 | −11,11 | 171,30 | −17 130 | 137 040 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 900 | −18,18 | 165,32 | −33 064 | 148 788 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −600 | 1 100 | −35,29 | 164,20 | −98 520 | 180 620 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 1 700 | −15,00 | 163,07 | −48 921 | 277 219 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 2 000 | −13,04 | 162,00 | −48 600 | 324 000 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 2 300 | −11,54 | 160,33 | −48 099 | 368 759 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 2 600 | −23,53 | 159,20 | −127 360 | 413 920 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 3 400 | −10,53 | 158,28 | −63 312 | 538 152 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 3 800 | −17,39 | 157,28 | −125 824 | 597 664 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 4 600 | −8,00 | 156,16 | −62 464 | 718 336 |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 174 952 | −2,78 | |||
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 0 | −100,00 | 146,65 | −58 660 | |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −600 | 400 | −60,00 | 145,49 | −87 294 | 58 196 |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 1 000 | −44,44 | 144,19 | −115 352 | 144 190 |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 600 | 1 800 | −47,06 | 143,27 | −229 232 | 257 886 |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 3 400 | −10,53 | 141,87 | −56 748 | 482 358 |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 3 800 | −17,39 | 140,94 | −112 752 | 535 572 |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 4 600 | −4,17 | 139,46 | −27 892 | 641 516 |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 4 800 | −4,00 | 138,24 | −27 648 | 663 552 |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 179 952 | −2,70 | |||
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 0 | −100,00 | 125,57 | −87 899 | |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 666 | 700 | −70,41 | 124,72 | −207 784 | 87 304 |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 000 | 2 366 | −29,71 | 123,57 | −123 570 | 292 367 |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 300 | 3 366 | −27,86 | 122,72 | −159 536 | 413 076 |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −334 | 4 666 | −6,68 | 121,59 | −40 611 | 567 339 |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 184 952 | −2,63 | |||
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 119,22 | −59 610 | |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 500 | 500 | −75,00 | 118,32 | −177 480 | 59 160 |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 300 | 2 000 | −39,39 | 117,21 | −152 373 | 234 420 |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 000 | 3 300 | −23,26 | 116,25 | −116 250 | 383 625 |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 4 300 | −6,52 | 114,71 | −34 413 | 493 253 |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 4 600 | −8,00 | 113,65 | −45 460 | 522 790 |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 189 952 | −2,56 | |||
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 112,96 | −11 296 | |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 100 | −75,00 | 112,29 | −33 687 | 11 229 |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 253 | 400 | −75,80 | 111,14 | −139 258 | 44 456 |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 802 | 1 653 | −52,16 | 110,09 | −198 382 | 181 979 |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 3 455 | −10,38 | 108,02 | −43 208 | 373 209 |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −445 | 3 855 | −10,35 | 106,52 | −47 401 | 410 635 |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −600 | 4 300 | −12,24 | 105,07 | −63 042 | 451 801 |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 4 900 | −2,00 | 103,51 | −10 351 | 507 199 |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 200 | 190 798 | −0,63 | |||
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −250 | 0 | −100,00 | 118,49 | −29 622 | |
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −375 | 250 | −60,00 | 117,44 | −44 040 | 29 360 |
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −180 | 625 | −22,36 | 116,42 | −20 956 | 72 762 |
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −185 | 805 | −18,69 | 115,15 | −21 303 | 92 696 |
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −60 | 990 | −5,71 | 113,81 | −6 829 | 112 672 |
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −150 | 1 050 | −12,50 | 111,80 | −16 770 | 117 390 |
2020-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 1 200 | 1 200 | 20,93 | 25 116 | 25 116 | |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −4 790 | 0 | −100,00 | |||
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 339 | 194 952 | −1,19 | |||
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 191 998 | −4,95 | |||
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 146,19 | −73 095 | |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 382 | 500 | −82,65 | 145,23 | −345 938 | 72 615 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 300 | 2 882 | −53,38 | 144,28 | −476 124 | 415 815 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 415 | 6 182 | −35,58 | 143,25 | −489 199 | 885 572 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 020 | 9 597 | −9,61 | 142,03 | −144 871 | 1 363 062 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 876 | 10 617 | −21,31 | 140,83 | −405 027 | 1 495 192 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 035 | 13 493 | −18,36 | 140,11 | −425 234 | 1 890 504 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −601 | 16 528 | −3,51 | 138,10 | −82 998 | 2 282 517 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 4 790 | 17 129 | 38,82 | 19,15 | 91 728 | 328 020 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 339 | 12 339 | 23,39 | 12,21 | 28 559 | 150 659 |
2020-12-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 4 790 | −67,61 | |||
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 4 790 | −67,61 | |||
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 197 291 | −2,47 | |||
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −34 | 50 175 | −0,07 | |||
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −701 | 0 | −100,00 | 162,63 | −114 004 | |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 502 | 701 | −78,11 | 161,65 | −404 448 | 113 317 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 907 | 3 203 | −47,58 | 160,58 | −466 806 | 514 338 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 358 | 6 110 | −27,85 | 159,73 | −376 643 | 975 950 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 000 | 8 468 | −10,56 | 158,35 | −158 350 | 1 340 908 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 509 | 9 468 | −36,78 | 157,17 | −865 850 | 1 488 086 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 922 | 14 977 | −24,73 | 156,27 | −769 161 | 2 340 456 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 733 | 19 899 | −15,80 | 155,16 | −579 212 | 3 087 529 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 402 | 23 632 | −5,60 | 154,25 | −216 258 | 3 645 236 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 25 034 | 66,52 | 19,15 | 191 500 | 479 401 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 15 034 | 49,83 | 12,21 | 61 050 | 183 565 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 34 | 10 034 | 0,34 | 14,22 | 483 | 142 683 |
2020-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 14 790 | −40,34 | |||
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −3 533 | 202 291 | −1,72 | |||
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 50 209 | −9,06 | |||
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 467 | 11 478 | −11,33 | |||
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −143 | 0 | −100,00 | 163,49 | −23 379 | |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 962 | 143 | −95,39 | 162,64 | −481 740 | 23 258 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 619 | 3 105 | −45,75 | 161,65 | −423 361 | 501 923 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −528 | 5 724 | −8,45 | 159,75 | −84 348 | 914 409 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 344 | 6 252 | −27,27 | 159,14 | −373 024 | 994 943 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 863 | 8 596 | −36,13 | 158,07 | −768 694 | 1 358 770 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 597 | 13 459 | −10,61 | 156,95 | −250 649 | 2 112 390 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −789 | 15 056 | −4,98 | 155,50 | −122 690 | 2 341 208 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 459 | 15 845 | −13,43 | 154,73 | −380 481 | 2 451 697 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 696 | 18 304 | −8,48 | 153,86 | −260 947 | 2 816 253 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 3 533 | 10 000 | 54,63 | 12,21 | 43 138 | 122 100 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 6 467 | 340,83 | 14,22 | 71 100 | 91 961 |
2020-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 1 467 | 1 467 | 12,21 | 17 912 | 17 912 | |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 24 790 | −28,74 | |||
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 55 209 | −8,30 | |||
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 55 209 | −8,30 | |||
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −392 | 0 | −100,00 | 153,50 | −60 172 | |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −312 | 392 | −44,32 | 152,74 | −47 655 | 59 874 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 | 704 | −12,44 | 151,00 | −15 100 | 106 304 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 804 | −46,54 | 150,09 | −105 063 | 120 672 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 100 | 1 504 | −73,16 | 149,38 | −612 458 | 224 668 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 893 | 5 604 | −51,26 | 148,35 | −874 227 | 831 353 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 335 | 11 497 | −22,49 | 147,22 | −490 979 | 1 692 588 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 108 | 14 832 | −12,44 | 146,12 | −308 021 | 2 167 252 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 660 | 16 940 | −8,92 | 145,25 | −241 115 | 2 460 535 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −600 | 18 600 | −3,12 | 144,09 | −86 454 | 2 680 074 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −800 | 19 200 | −4,00 | 142,43 | −113 944 | 2 734 656 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 10 000 | 100,00 | 14,22 | 71 100 | 142 200 |
2020-12-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-11-24 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 34 790 | −22,33 | |||
2020-11-24 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 17 945 | −21,79 | |||
2020-11-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 724 | 0 | −100,00 | 101,21 | −680 536 | |
2020-11-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 836 | 6 724 | −50,41 | 100,12 | −684 420 | 673 207 |
2020-11-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 440 | 13 560 | −9,60 | 99,31 | −143 006 | 1 346 644 |
2020-11-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-11-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 44 790 | −18,25 | |||
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 205 824 | −2,37 | |||
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 600 | 0 | −100,00 | 99,20 | −158 720 | |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 003 | 1 600 | −65,24 | 98,34 | −295 315 | 157 344 |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 623 | 4 603 | −36,30 | 97,45 | −255 611 | 448 562 |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 179 | 7 226 | −36,64 | 96,44 | −403 023 | 696 875 |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 895 | 11 405 | −20,24 | 95,36 | −276 067 | 1 087 581 |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 14 300 | −4,67 | 94,42 | −66 094 | 1 350 206 |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-11-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 54 790 | −15,43 | |||
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 210 824 | −2,32 | |||
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 80,11 | −24 033 | |
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 400 | 300 | −82,35 | 79,31 | −111 034 | 23 793 |
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 404 | 1 700 | −79,02 | 78,37 | −501 881 | 133 229 |
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 971 | 8 104 | −38,02 | 77,47 | −385 103 | 627 817 |
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 925 | 13 075 | −12,83 | 76,51 | −147 282 | 1 000 368 |
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-11-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-11-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 64 790 | −13,37 | |||
2020-11-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 215 824 | −2,26 | |||
2020-11-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 100 | 0 | −100,00 | 67,88 | −74 668 | |
2020-11-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −13 900 | 1 100 | −92,67 | 67,11 | −932 829 | 73 821 |
2020-11-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-11-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-10-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 74 790 | −11,79 | |||
2020-10-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 220 824 | −2,21 | |||
2020-10-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 100 | 0 | −100,00 | 70,99 | −149 079 | |
2020-10-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 844 | 2 100 | −76,52 | 70,21 | −480 517 | 147 441 |
2020-10-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 056 | 8 944 | −40,37 | 69,42 | −420 408 | 620 892 |
2020-10-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-10-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 84 790 | −10,55 | |||
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 225 824 | −2,17 | |||
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 73,81 | −14 762 | |
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 100 | 200 | −93,94 | 73,12 | −226 672 | 14 624 |
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 005 | 3 300 | −64,54 | 71,92 | −431 880 | 237 336 |
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 695 | 9 305 | −37,97 | 71,24 | −405 712 | 662 888 |
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-10-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-10-13 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 94 790 | −9,54 | |||
2020-10-13 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 230 824 | −2,12 | |||
2020-10-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 279 | 0 | −100,00 | 75,32 | −322 294 | |
2020-10-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −7 421 | 4 279 | −63,43 | 74,50 | −552 864 | 318 786 |
2020-10-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 300 | 11 700 | −22,00 | 73,30 | −241 890 | 857 610 |
2020-10-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-10-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-10-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 104 790 | −8,71 | |||
2020-10-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 235 824 | −2,08 | |||
2020-10-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 910 | 0 | −100,00 | 71,50 | −208 065 | |
2020-10-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 700 | 2 910 | −61,76 | 70,57 | −331 679 | 205 359 |
2020-10-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −7 390 | 7 610 | −49,27 | 69,54 | −513 901 | 529 199 |
2020-10-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 19,15 | 191 500 | 287 250 |
2020-10-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-09-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 114 790 | −8,01 | |||
2020-09-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −7 197 | 211 998 | −3,28 | |||
2020-09-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 178 | 0 | −100,00 | 70,64 | −718 974 | |
2020-09-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −7 019 | 10 178 | −40,82 | 69,75 | −489 575 | 709 916 |
2020-09-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 17 197 | 138,95 | 19,15 | 191 500 | 329 323 |
2020-09-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 7 197 | 7 197 | 20,93 | 150 633 | 150 633 | |
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 124 790 | −7,42 | |||
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 124 790 | −7,42 | |||
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 789 | 0 | −100,00 | 69,06 | −123 548 | |
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 210 | 1 789 | −70,18 | 67,94 | −286 027 | 121 545 |
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 601 | 5 999 | −63,86 | 67,11 | −711 433 | 402 593 |
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 400 | 16 600 | −17,00 | 66,16 | −224 944 | 1 098 256 |
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-09-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 134 790 | −6,91 | |||
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 134 790 | −6,91 | |||
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −34 | 60 209 | −0,06 | |||
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 168 | 0 | −100,00 | 63,53 | −328 323 | |
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 210 | 5 168 | −66,39 | 62,79 | −641 086 | 324 499 |
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 574 | 15 378 | −14,34 | 61,85 | −159 202 | 951 129 |
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 082 | 17 952 | −10,39 | 60,86 | −126 711 | 1 092 559 |
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 034 | 99,66 | 19,15 | 191 500 | 383 651 |
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 34 | 10 034 | 0,34 | 14,22 | 483 | 142 683 |
2020-09-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 144 790 | −6,46 | |||
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 144 790 | −6,46 | |||
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 60 243 | −7,66 | |||
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 467 | 22 945 | −6,01 | |||
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 960 | 0 | −100,00 | 57,88 | −287 085 | |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 457 | 4 960 | −56,56 | 56,82 | −366 887 | 281 827 |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −8 655 | 11 417 | −43,12 | 55,88 | −483 641 | 637 982 |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 395 | 20 072 | −24,16 | 54,69 | −349 743 | 1 097 738 |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 26 467 | 60,73 | 19,15 | 191 500 | 506 843 |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 16 467 | 43,60 | 14,22 | 71 100 | 234 161 |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 1 467 | 11 467 | 14,67 | 12,21 | 17 912 | 140 012 |
2020-09-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 154 790 | −6,07 | |||
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 154 790 | −6,07 | |||
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 65 243 | −7,12 | |||
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 65 243 | −7,12 | |||
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 823 | 0 | −100,00 | 66,52 | −121 266 | |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 807 | 1 823 | −72,50 | 64,81 | −311 542 | 118 149 |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −14 700 | 6 630 | −68,92 | 64,16 | −943 152 | 425 381 |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −8 670 | 21 330 | −28,90 | 63,09 | −546 990 | 1 345 710 |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 30 000 | 50,00 | 19,15 | 191 500 | 574 500 |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 20 000 | 33,33 | 14,22 | 71 100 | 284 400 |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 15 000 | 50,00 | 12,21 | 61 050 | 183 150 |
2020-09-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 164 790 | −5,72 | |||
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 164 790 | −5,72 | |||
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 29 412 | −14,53 | |||
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 100 | 0 | −100,00 | 67,31 | −74 041 | |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 058 | 1 100 | −65,17 | 66,40 | −136 651 | 73 040 |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −8 690 | 3 158 | −73,35 | 65,35 | −567 892 | 206 375 |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −9 849 | 11 848 | −45,39 | 64,56 | −635 851 | 764 907 |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 303 | 21 697 | −13,21 | 63,65 | −210 236 | 1 381 014 |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 25 000 | 66,67 | 19,15 | 191 500 | 478 750 |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 15 000 | 50,00 | 12,21 | 61 050 | 183 150 |
2020-08-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-08-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 174 790 | −5,41 | |||
2020-08-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 174 790 | −5,41 | |||
2020-08-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 69,06 | −1 381 200 | |
2020-08-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-08-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-08-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 184 790 | −5,13 | |||
2020-08-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 184 790 | −5,13 | |||
2020-08-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 74,27 | −1 485 400 | |
2020-08-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-08-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-08-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 194 790 | −4,88 | |||
2020-08-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 194 790 | −4,88 | |||
2020-08-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 74,89 | −1 497 800 | |
2020-08-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-08-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 204 790 | −4,66 | |||
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 204 790 | −4,66 | |||
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −900 | 0 | −100,00 | 80,43 | −72 387 | |
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −7 228 | 900 | −88,93 | 79,72 | −576 216 | 71 748 |
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 548 | 8 128 | −40,57 | 78,73 | −436 794 | 639 917 |
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 940 | 13 676 | −22,37 | 77,68 | −306 059 | 1 062 352 |
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 384 | 17 616 | −11,92 | 76,79 | −183 067 | 1 352 733 |
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 214 790 | −4,45 | |||
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 214 790 | −4,45 | |||
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 90,64 | −18 128 | |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 200 | −66,67 | 88,76 | −35 504 | 17 752 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −354 | 600 | −37,11 | 87,41 | −30 943 | 52 446 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 000 | 954 | −51,18 | 86,37 | −86 370 | 82 397 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 469 | 1 954 | −63,97 | 85,58 | −296 877 | 167 223 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 409 | 5 423 | −30,76 | 84,53 | −203 633 | 458 406 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 425 | 7 832 | −30,43 | 83,17 | −284 857 | 651 387 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 488 | 11 257 | −28,50 | 82,49 | −370 215 | 928 590 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 205 | 15 745 | −12,28 | 81,23 | −179 112 | 1 278 966 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 650 | 17 950 | −8,42 | 80,49 | −132 808 | 1 444 796 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −400 | 19 600 | −2,00 | 78,77 | −31 508 | 1 543 892 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-07-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 224 790 | −4,26 | |||
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 224 790 | −4,26 | |||
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 77,54 | −15 508 | |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −200 | 200 | −50,00 | 76,12 | −15 224 | 15 224 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −737 | 400 | −64,82 | 75,45 | −55 607 | 30 180 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 431 | 1 137 | −55,72 | 74,26 | −106 266 | 84 434 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 330 | 2 568 | −47,57 | 73,27 | −170 719 | 188 157 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 987 | 4 898 | −44,87 | 72,33 | −288 380 | 354 272 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −900 | 8 885 | −9,20 | 71,23 | −64 107 | 632 879 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −700 | 9 785 | −6,68 | 70,01 | −49 007 | 685 048 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 747 | 10 485 | −14,28 | 68,99 | −120 526 | 723 360 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −492 | 12 232 | −3,87 | 67,90 | −33 407 | 830 553 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 463 | 12 724 | −21,39 | 66,58 | −230 567 | 847 164 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 600 | 16 187 | −13,84 | 65,87 | −171 262 | 1 066 238 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 213 | 18 787 | −6,06 | 64,44 | −78 166 | 1 210 634 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 234 790 | −4,09 | |||
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 234 790 | −4,09 | |||
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 143 | 0 | −100,00 | 62,16 | −71 049 | |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 619 | 1 143 | −93,18 | 61,35 | −958 226 | 70 123 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 238 | 16 762 | −16,19 | 60,27 | −195 154 | 1 010 246 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 19,15 | 191 500 | 383 000 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 20,93 | 209 300 | 209 300 | |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 631 | 244 790 | −6,00 | |||
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −24 121 | 260 421 | −8,48 | |||
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −22 936 | 240 824 | −8,70 | |||
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −13 769 | 0 | −100,00 | 60,98 | −839 634 | |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −7 739 | 13 769 | −35,98 | 60,05 | −464 727 | 826 828 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −17 393 | 21 508 | −44,71 | 58,97 | −1 025 665 | 1 268 327 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −23 787 | 38 901 | −37,95 | 58,21 | −1 384 641 | 2 264 427 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 15 631 | 62 688 | 33,22 | 19,15 | 299 334 | 1 200 475 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 24 121 | 47 057 | 105,17 | 19,15 | 461 917 | 901 142 |
2020-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 22 936 | 22 936 | 12,21 | 280 049 | 280 049 | |
2020-07-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 631 | 284 542 | −5,21 | |||
2020-07-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −24 121 | 300 173 | −7,44 | |||
2020-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −21 385 | 0 | −100,00 | 64,57 | −1 380 829 | |
2020-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −12 967 | 21 385 | −37,75 | 63,56 | −824 183 | 1 359 231 |
2020-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 400 | 34 352 | −13,58 | 62,83 | −339 282 | 2 158 336 |
2020-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 15 631 | 39 752 | 64,80 | 19,15 | 299 334 | 761 251 |
2020-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 24 121 | 24 121 | 19,15 | 461 917 | 461 917 | |
2020-07-01 |
|
4 | ADAP |
Adaptimmune Therapeutics PLC
Option to purchase Ordinary Shares |
A - Award | 144 000 | 144 000 | |||||
2020-06-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 631 | 324 294 | −4,60 | |||
2020-06-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −24 121 | 339 925 | −6,63 | |||
2020-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 500 | 0 | −100,00 | 64,94 | −97 410 | |
2020-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −14 279 | 1 500 | −90,49 | 64,16 | −916 141 | 96 240 |
2020-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −23 973 | 15 779 | −60,31 | 63,37 | −1 519 169 | 999 915 |
2020-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 15 631 | 39 752 | 64,80 | 19,15 | 299 334 | 761 251 |
2020-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 24 121 | 24 121 | 19,15 | 461 917 | 461 917 | |
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 631 | 364 046 | −4,12 | |||
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −24 121 | 379 677 | −5,97 | |||
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 66,58 | −19 974 | |
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 000 | 300 | −76,92 | 65,69 | −65 690 | 19 707 |
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −16 320 | 1 300 | −92,62 | 64,08 | −1 045 786 | 83 304 |
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −22 132 | 17 620 | −55,68 | 63,40 | −1 403 169 | 1 117 108 |
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 15 631 | 39 752 | 64,80 | 19,15 | 299 334 | 761 251 |
2020-06-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 24 121 | 24 121 | 19,15 | 461 917 | 461 917 | |
2020-06-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 631 | 403 798 | −3,73 | |||
2020-06-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −24 121 | 419 429 | −5,44 | |||
2020-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −9 080 | 0 | −100,00 | 58,95 | −535 266 | |
2020-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −30 672 | 9 080 | −77,16 | 58,33 | −1 789 098 | 529 636 |
2020-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 15 631 | 39 752 | 64,80 | 19,15 | 299 334 | 761 251 |
2020-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 24 121 | 24 121 | 19,15 | 461 917 | 461 917 | |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −39 752 | 443 550 | −8,23 | |||
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −47 737 | 70 243 | −40,46 | |||
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −11 467 | 34 412 | −24,99 | |||
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 525 | 0 | −100,00 | 59,81 | −270 640 | |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −30 381 | 4 525 | −87,04 | 59,11 | −1 795 821 | 267 473 |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −48 079 | 34 906 | −57,94 | 58,13 | −2 794 832 | 2 029 086 |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −12 797 | 82 985 | −13,36 | 57,15 | −731 349 | 4 742 593 |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 174 | 95 782 | −3,21 | 56,28 | −178 633 | 5 390 611 |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 39 752 | 98 956 | 67,14 | 19,15 | 761 251 | 1 895 007 |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 47 737 | 59 204 | 416,30 | 14,22 | 678 820 | 841 881 |
2020-06-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 11 467 | 11 467 | 12,21 | 140 012 | 140 012 | |
2020-06-04 |
|
4/A | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 770 | 0 | −100,00 | 50,48 | −240 790 | |
2020-06-04 |
|
4/A | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −125 044 | 0 | −100,00 | 78,16 | −9 773 439 | |
2020-05-28 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −42 570 | 117 980 | −26,52 | |||
2020-05-28 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −82 474 | 263 760 | −23,82 | |||
2020-05-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −125 044 | 0 | −100,00 | 66,54 | −8 320 428 | |
2020-05-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 82 474 | 125 044 | 193,74 | 12,21 | 1 007 008 | 1 526 787 |
2020-05-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 42 570 | 42 570 | 14,22 | 605 345 | 605 345 | |
2020-05-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −112 481 | 346 234 | −24,52 | |||
2020-05-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −12 563 | 45 879 | −21,50 | |||
2020-05-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −125 044 | 0 | −100,00 | 78,16 | −9 773 439 | |
2020-05-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 112 481 | 125 044 | 895,34 | 12,21 | 1 373 393 | 1 526 787 |
2020-05-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 12 563 | 12 563 | 12,21 | 153 394 | 153 394 | |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −125 044 | 58 442 | −68,15 | |||
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −17 744 | 0 | −100,00 | 62,65 | −1 111 662 | |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −19 817 | 17 744 | −52,76 | 63,59 | −1 260 163 | 1 128 341 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −59 913 | 37 561 | −61,47 | 64,72 | −3 877 569 | 2 430 948 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −25 905 | 97 474 | −21,00 | 65,46 | −1 695 741 | 6 380 648 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 365 | 123 379 | −1,09 | 66,43 | −90 677 | 8 196 067 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 124 744 | −0,24 | 67,23 | −20 169 | 8 386 539 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 125 044 | 125 044 | 12,21 | 1 526 787 | 1 526 787 | |
2020-05-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 770 | 0 | −100,00 | 50,48 | −240 790 | |
2020-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 4 770 | −67,70 | 47,15 | −471 500 | 224 906 |
2020-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 14 770 | −40,37 | 48,81 | −488 100 | 720 924 |
2020-04-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 24 770 | −28,76 | 32,00 | −320 000 | 792 640 |
2020-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 34 770 | −22,34 | 32,81 | −328 100 | 1 140 804 |
2020-03-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 44 770 | −18,26 | 28,37 | −283 700 | 1 270 125 |
2020-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 54 770 | −15,44 | 29,13 | −291 300 | 1 595 450 |
2020-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 64 770 | −13,37 | 23,00 | −230 000 | 1 489 710 |
2020-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 74 770 | −11,80 | 27,98 | −279 800 | 2 092 065 |
2020-03-03 |
|
4 | MRNA |
Moderna, Inc.
Restricted Stock Units |
A - Award | 28 924 | 28 924 | |||||
2020-03-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
A - Award | 161 120 | 161 120 | |||||
2020-03-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 84 770 | −10,55 | 23,38 | −233 800 | 1 981 923 |
2020-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 94 770 | −9,54 | 18,47 | −184 700 | 1 750 402 |
2019-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −100 000 | 104 770 | −48,84 | 18,54 | −1 854 000 | 1 942 436 |
2019-07-03 |
|
4 | ADAP |
Adaptimmune Therapeutics PLC
Option to purchase Ordinary Shares |
A - Award | 124 000 | 124 000 | |||||
2019-03-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
A - Award | 339 195 | 339 195 | |||||
2018-12-07 | 3 | MRNA |
Moderna, Inc.
Common Stock |
409 540 | ||||||||
2018-12-07 | 3 | MRNA |
Moderna, Inc.
Common Stock |
409 540 | ||||||||
2018-12-07 | 3 | MRNA |
Moderna, Inc.
Common Stock |
409 540 | ||||||||
2018-06-26 |
|
4 | ADAP |
Adaptimmune Therapeutics PLC
Option to purchase Ordinary Shares |
A - Award | 124 000 | 124 000 | |||||
2017-07-03 |
|
4 | ADAP |
Adaptimmune Therapeutics PLC
Option to purchase Ordinary Shares |
A - Award | 144 000 | 144 000 | |||||
2016-12-01 |
|
4 | ADAP |
Adaptimmune Therapeutics PLC
Option to purchase Ordinary Shares |
A - Award | 288 000 | 288 000 |